HHAM
PDLI

HITE Hedge Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

HITE Hedge Asset Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-150,412
Closed -$488K – 127
2019
Q4 		$488K Buy
+150,412
New +$437K 0.1% 68

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Brandes Investment Partners
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

HITE Hedge Asset Management's PDLI Position: Q1 2020 in Review

HITE Hedge Asset Management sold out of PDL BioPharma, Inc. (PDLI) in Q1 2020, closing a stake of 150,412 shares — an estimated $488K sold.

HITE Hedge Asset Management first reported a position in PDLI in Q4 2019 and held it in 1 quarter. The position peaked at $488K in Q4 2019. 132 funds tracked by Wall St. Rank hold PDLI as of Q1 2020.

  • HITE Hedge Asset Management reported no remaining PDL BioPharma, Inc. position as of Q1 2020 after selling out during the quarter.
  • HITE Hedge Asset Management sold 150,412 PDL BioPharma, Inc. shares in Q1 2020, an estimated $488K.
  • HITE Hedge Asset Management first reported a position in PDL BioPharma, Inc. in Q4 2019 and held it in 1 quarter.
  • HITE Hedge Asset Management's PDL BioPharma, Inc. position peaked at $488K in Q4 2019.
  • 132 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2020.

Based on HITE Hedge Asset Management's 13F filing for Q1 2020, filed 14 May 2020.